Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients With High-Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial

NCT00819208 is registered in ClinicalTrials.gov with Canadian Cancer Trials Group as lead sponsor.

NCT NCT00819208
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00819208 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III Study of the Impact of a Physical Activity Program on Disease-Free Survival in Patients With High-Risk Stage II or Stage III Colon Cancer: A Randomized Controlled Trial
Lead sponsor
Canadian Cancer Trials Group
Phase
Not applicable
Overall status
Completed
Start date
June 2, 2009
Completion date
March 17, 2026
Enrollment
889 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorder, cognitive/functional effects, colorectal cancer, depression, excercise, fatigue, psychosocial effects of cancer and its treatment, sleep disorders